|
本帖最后由 甲米 于 2013-6-13 17:16 编辑
GSK中国研发中心总裁藏敬五Nature Medicine论文造假东窗事发己经离职
作者:formergskemployees
据 ...
甲米 发表于 2013-6-4 18:16
-----------------------------------------------------------------------------------------
GSK Says Paper Published In Nature Medicine By Company Scientists To Be Retracted
PharmAsia
Tue, 11 Jun 2013 10:35:59 GMT
GSK confirms dismissal of R&D China Head Jingwu Zang. Internal GSK communication seen by PharmAsia News alleges “disturbing efforts” by employees to undermine an internal investigation into a paper on preclinical research. GSK has suspended programs related to IL-7 receptor signaling pathway, appointed an interim head of discovery in China, and R&D President Patrick Vallance is headed to Shanghai to discuss with employees.
-----------------------------------------
此事将在国际上大大的打击新药研发领域中国科学家的信用。
|
|